acetylcysteine has been researched along with Prostatic Neoplasms, Castration-Resistant in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baker, B; Chatterjee, A; Cheng, PW; Ingersoll, MA; Kosmacek, EA; Lin, MF; Miller, DR; Oberley-Deegan, RE; Shrishrimal, S; Zhu, Y | 1 |
1 other study(ies) available for acetylcysteine and Prostatic Neoplasms, Castration-Resistant
| Article | Year |
|---|---|
p66Shc protein through a redox mechanism enhances the progression of prostate cancer cells towards castration-resistance.
Topics: Acetylcysteine; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Progression; Drug Resistance, Neoplasm; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Heterografts; Humans; Hydrogen Peroxide; Kallikreins; Lymphatic Metastasis; Male; Mice; Mice, Nude; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Reactive Oxygen Species; Receptors, Androgen; Src Homology 2 Domain-Containing, Transforming Protein 1 | 2019 |